Aura Biosciences

IPO

Public · Boston, United States · Founded 2009 · $233.9M raised

Employees
51–200
Founded
2009
Business Model
B2B
Total Funding
$233.9M
Last Round
$80.5M Series EMar 2021
Rounds
7
Type
Public

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Aura Biosciences is a clinical-stage biotechnology company developing virus-like drug conjugates to treat ocular cancers. Its lead candidate, bel-sar, is being developed as a first-line, potentially curative and vision-preserving treatment for early choroidal melanoma. Aura is also advancing clinical studies of bel-sar for ocular metastases and ocular-surface cancers.

Summary

Aura Biosciences is a Biotech company based in Boston, United States, founded in 2009. It has raised $233.9M in total across 7 rounds, most recently a $80.5M Series E round in Mar 2021. Investors include Advent Life Sciences, Medicxi and Matrix Capital Management.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

IPOMay 2025
$260.3M

Sign up to see all 8 events

Funding: Series A through Series E. Amounts, valuations, and investors where available.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Aura Biosciences on Indexed.vc
<a href="https://indexed.vc/companies/aura-biosciences"><img src="https://indexed.vc/api/badge/company/aura-biosciences" alt="Aura Biosciences on Indexed.vc" width="260" height="76" /></a>